Skip to main content

Table 2 Number of individuals examined for B. timori from 2001 to 2004 grouped by mf density and the numbers of individuals who claimed to have been treated with DEC/albendazole in the previous year.

From: Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timoriand of intestinal helminths on Alor Island, Indonesia

Mf/ml 2001 No. (%) 2002 No. (%) 2003 No. (%) 2004 No. (%)
  Examined* Treated** Examined* Treated** Examined* Treated** Examined* Treated**
0 429 (73.2) 0 634 (82.4) 126 (19.9) 721 (93.9) 482 (66.9) 677 (96.2) 548 (80.9)
1–100 66 (11.3) 0 90 (11.7) 22 (24.4) 25 (3.3) 17 (68.0) 20 (2.8) 14 (70.0)
101–500 42 (7.2) 0 29 (3.8) 6 (20.7) 14 (1.8) 6 (42.9) 4 (0.6) 2 (50.0)
>500 49 (8.3) 0 16 (2.1) 1 (6.3) 8 (1.0) 4 (50.0) 3 (0.4) 0 (0)
Total 586 (100) 0 769 (100) 155 (20.5) 768 (100) 509 (66.3) 704 (100) 564 (80.1)
  1. *percentage of total examined, **percentage of negative or positive examined